Spiro Wave emergency ventilator gains FDA authorization to address COVID-19 demand
A new project designed to help address the growing need for ventilator hardware in order to treat the most serious cases of COVID-19 achieved an important milestone today, getting FDA Emergency Use Authorization (EUA) for its units to be used and scaled for production. The hardware, dubbed ‘Spiro Wave,’ is an emergency automated resuscitator that can be produced for under $5,000, and that a team of engineers, doctors and researchers has already begun producing and delivering to care facilities.
The Spiro Wave essentially replicates the functionality of a manual resuscitator, a portable device is typically operated manually to provide ventilation to emergency patients in case of emergency, but it automated the process, while still working with the same types of bags that are typically used with the manual version for easier sourcing of supplies.
Spiro Wave is based on MIT’s open-source E-Vent prototype design, which was created by researchers at the institution as one way to alleviate the shortage that resulted from the COVID-19 crisis. From that design, the team behind Spiro Wave, which includes the co-founders of Newly, 10XBeta and Boyce Technologies, were able to go from design to production of their emergency ventilator in just a few weeks.
Manufacturing partner Boyce says that it can hopefully ramp production not as much as 500 per day, at its Long Island City production facility in Queens, and the first few hundred are already shipping out to facilities in NYC starting this week. The team is also now looking for international production scaling assistance with partners who are registered to produce medical devices with the FDA in order to increase supply even further.
The team behind this note that it’s not meant to replace a full-fledged ventilator, but that it will instead help alleviate the drain on those resources used in emergency care situations where a respirator would be just as effective, but where the manual version is impractical in terms of staffing and prolonged use. Like so many other measures granted EUA, this may not be an ideal replacement for fully FDA-approved equipment and therapies, but it’s an innovative, scalable solution that could mean big differences in the level of care at overburdened healthcare facilities.
A new project designed to help address the growing need for ventilator hardware in order to treat the most serious cases of COVID-19 achieved an important milestone today, getting FDA Emergency Use Authorization (EUA) for its units to be used and scaled for production. The hardware, dubbed ‘Spiro Wave,’ is…
Recent Posts
- Quordle today – hints and answers for Saturday, April 20 (game #817)
- NYT Strands today — hints, answers and spangram for Saturday, April 20 (game #48)
- Classic PlayStation and Saturn games may be coming to your iPhone next
- You can buy a refurbished Steam Deck for almost half off
- 16 Best Hair Straighteners We’ve Tested (2024): Flat Irons, Hot Combs, and Straightening Brushes
Archives
- April 2024
- March 2024
- February 2024
- January 2024
- December 2023
- November 2023
- October 2023
- September 2023
- August 2023
- July 2023
- June 2023
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- November 2019
- December 2011